Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

TALENTS Training AlliancE for Novel Microbiome-Modulating TherapieS

Coordinator
Universitat Des Saarlandes, Germany
Runs
1 January 2023 to 31 December 2027
Status
Running
EU funding
€1.5m
Total cost
—
Partners
17 organisations in 5 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101081463

What the project is doing

In the project's own words, from its summary on CORDIS.

TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as needed for the next generation of drug researchers. Research projects are structured in 3 clusters (PCs): PC1 will investigate the microbiome by transcriptomic and metagenomic analysis of diseases to identify and isolate microorganisms/metabolites for therapeutically modifying the microbiota.

PC2 will focus on pathoblockers targeting virulence factors as alternative to traditional antibiotics with lower risk of resistance development. PC3 will address the delivery needs across biological barriers, to achieve efficient and targeted transport to the site of action. Throughout the PC structure of 15 individual, but interconnected research projects, we aim to develop and exchange disease models, analytical methods and microbiome-related results.

By generating knowledge on correlations and causalities between microbiota and disease TALENTS will advance the development of novel microbiome-modulating therapies TALENTS is builds on an earlier joint venture of Saarland University, University Clinics Saarland and Helmholtz Institute for Pharmaceutical Research Saarland to foster transdisciplinary doctoral training between different faculties and institutions. In addition, TALENTS is intersectorial by implementing a unique supervision structure for each DC with an external expert advisor and translation-oriented training for individual career development, also including secondments in a complementary industrial or clinical sector.

Working on challenging research projects, the candidates will acquire specific knowledge and skills at the interface of clinical medicine, microbiology and pharmaceutical science, pivotal for state-of-the-art infection research and microbiome interventions. By collaborations of experts from natural sciences, medicine, and bioinformatics, TALENTS provides high-level multidisciplinary and intersectorial training.

Topics

Who is involved

OrganisationCityCountryRole
Universitat Des SaarlandesSaarbruckenGermanyCoordinator
Universitat LinzLinzAustriaAssociatedpartner
Vib VzwZwijnaarde - GentBelgiumAssociatedpartner
Biosolveit GmbHSankt AugustinGermanyAssociatedpartner
Bundesinstitut Fuer RisikobewertungBerlinGermanyAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyAssociatedpartner
Evotec International GmbHHamburgGermanyAssociatedpartner
Friedrich-Alexander-Universitaet Erlangen-NuernbergErlangenGermanyAssociatedpartner
Helmholtz-Zentrum Fur Infektionsforschung GmbHBraunschweigGermanyAssociatedpartner
Lactopia GmbHSaarbruckenGermanyAssociatedpartner
Mybiotech GmbHUberherrnGermanyAssociatedpartner
Pharmabiotec GmbHSaarbrueckenGermanyAssociatedpartner
Pharmacelsus GmbHSaarbruckenGermanyAssociatedpartner
Universitaet MuensterMuensterGermanyAssociatedpartner
URSAPHARM Arzneimittel GmbHSaarbruckenGermanyAssociatedpartner
FiralisHuningueFranceAssociatedpartner
University of GlasgowGlasgowUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI